Perioperative Use of Methotrexate and Tumor Necrosis Factor α Inhibitors Combination Therapy Is Not Likely to Increase Post-Operative Infection Rate in the National Veterans Health Administration Administrative Databases

ISSN Print: 2163-9914
ISSN Online: 2164-005X
www.scirp.net/journal/ojra
E-mail: [email protected]

Citations

"Perioperative Use of Methotrexate and Tumor Necrosis Factor α Inhibitors Combination Therapy Is Not Likely to Increase Post-Operative Infection Rate in the National Veterans Health Administration Administrative Databases"
written by Hsin-Hsuan Juo, Anders Peck, Sarah E. Monsell, Bernard Ng,
published by Open Journal of Rheumatology and Autoimmune Diseases, Vol.9 No.1, 2019

has been cited by the following article(s):

[1]	Effect of tumour necrosis factor‐a inhibitors exposure on surgical site infections in rheumatoid arthritis patients undergoing elective orthopaedic surgery: A meta …
	International Wound Journal, 2024

[2]	Australian recommendations on perioperative use of disease‐modifying anti‐rheumatic drugs in people with inflammatory arthritis undergoing elective surgery
	Internal Medicine …, 2023

Top

[1]	Perioperative biologic use and postoperative outcomes in patients with inflammatory arthritis: a systematic review BMC Rheumatology, 2026 DOI:10.1186/s41927-026-00650-y

[2]	Effect of tumour necrosis factor‐a inhibitors exposure on surgical site infections in rheumatoid arthritis patients undergoing elective orthopaedic surgery: A meta‐analysis International Wound Journal, 2024 DOI:10.1111/iwj.14538